Triple-negative breast cancer, which is characterized by the lack of expression of the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2), is a type of breast cancer with aggressive tumor behavior. Here, ERBB2 is linked to neoplasm.